James C Blair - Net Worth and Insider Trading
James C Blair Net Worth
The estimated net worth of James C Blair is at least $83 Million dollars as of 2024-11-06. James C Blair is the 10% Owner of Achillion Pharmaceuticals Inc and owns about 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $54 Million. James C Blair is the Director, 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. James C Blair is also the 10% Owner of Esperion Therapeutics Inc and owns about 2,102,188 shares of Esperion Therapeutics Inc (ESPR) stock worth over $4 Million. Besides these, James C Blair also holds Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Orexigen Therapeutics Inc (OREXQ) , Clovis Oncology Inc (CLVSQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , NuVasive Inc (NUVA) . Details can be seen in James C Blair's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James C Blair has not made any transactions after 2019-08-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James C Blair
James C Blair Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James C Blair owns 31 companies in total, including Clovis Oncology Inc (CLVSQ) , Obalon Therapeutics Inc (OBLN) , and aTyr Pharma Inc (ATYR) among others .
Click here to see the complete history of James C Blair’s form 4 insider trades.
Insider Ownership Summary of James C Blair
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CLVSQ | Clovis Oncology Inc | 2019-08-20 | director |
OBLN | Obalon Therapeutics Inc | 2019-08-06 | 10 percent owner |
ATYR | aTyr Pharma Inc | 2015-05-06 | director & 10 percent owner |
2019-05-03 | 10 percent owner | ||
2018-08-21 | 10 percent owner | ||
2017-12-18 | 10 percent owner | ||
2017-12-11 | 10 percent owner | ||
2016-11-01 | 10 percent owner | ||
2016-09-09 | 10 percent owner | ||
2013-09-24 | 10 percent owner | ||
2016-03-02 | 10 percent owner | ||
2015-06-24 | 10 percent owner | ||
2013-07-01 | 10 percent owner | ||
2014-11-19 | 10 percent owner | ||
2014-10-15 | 10 percent owner | ||
2013-10-29 | 10 percent owner | ||
2014-08-12 | 10 percent owner | ||
2014-07-31 | 10 percent owner | ||
2014-05-21 | director & 10 percent owner | ||
2014-05-01 | 10 percent owner | ||
2014-03-17 | 10 percent owner | ||
2011-06-02 | 10 percent owner | ||
2013-11-13 | 10 percent owner | ||
2013-01-18 | 10 percent owner | ||
2013-01-14 | 10 percent owner | ||
2011-12-22 | 10 percent owner | ||
2006-05-09 | director & 10 percent owner | ||
2006-12-06 | director & 10 percent owner | ||
2006-04-12 | 10 percent owner | ||
2004-06-25 | 10 percent owner | ||
2016-10-05 | 10 percent owner |
James C Blair Latest Holdings Summary
James C Blair currently owns a total of 10 stocks. Among these stocks, James C Blair owns 8,032,129 shares of Achillion Pharmaceuticals Inc (ACHN) as of August 20, 2010, with a value of $54 Million and a weighting of 65.6%. James C Blair owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 26.61%. James C Blair also owns 2,102,188 shares of Esperion Therapeutics Inc (ESPR) as of July 1, 2013, with a value of $4 Million and a weighting of 5.38%. The other 7 stocks Alimera Sciences Inc (ALIM) , Ocera Therapeutics Inc (OCRX) , Orexigen Therapeutics Inc (OREXQ) , Clovis Oncology Inc (CLVSQ) , Novation Companies Inc (NOVCQ) , Regado Biosciences Inc (RGDO) , NuVasive Inc (NUVA) have a combined weighting of 2.41% among all his current holdings.
Latest Holdings of James C Blair
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ACHN | Achillion Pharmaceuticals Inc | 2010-08-20 | 8,032,129 | 6.76 | 54,297,192 |
ZGNX | Zogenix Inc | 2010-11-29 | 825,323 | 26.68 | 22,019,618 |
ESPR | Esperion Therapeutics Inc | 2013-07-01 | 2,102,188 | 2.12 | 4,456,639 |
ALIM | Alimera Sciences Inc | 2011-06-02 | 279,297 | 5.54 | 1,547,305 |
OCRX | Ocera Therapeutics Inc | 2013-07-15 | 246,386 | 1.79 | 441,031 |
OREXQ | Orexigen Therapeutics Inc | 2011-12-22 | 301,806 | 0.01 | 1,600 |
CLVSQ | Clovis Oncology Inc | 2019-08-20 | 63,544 | 0.02 | 953 |
NOVCQ | Novation Companies Inc | 2006-05-15 | 1,062,474 | 0.00 | 106 |
RGDO | Regado Biosciences Inc | 2013-08-27 | 2,603,208 | 0.00 | 0 |
NUVA | NuVasive Inc | 2006-12-06 | 0 | 39.75 | 0 |
Holding Weightings of James C Blair
James C Blair Form 4 Trading Tracker
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 0 shares on August 20, 2010, which brought James C Blair around $0.
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost James C Blair around $9 Million.
According to the SEC Form 4 filings, James C Blair has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the acquisition of 285,714 shares on July 1, 2013, which cost James C Blair around $4 Million.
More details on James C Blair's insider transactions can be found in the Insider Trading History of James C Blair table.Insider Trading History of James C Blair
- 1
James C Blair Trading Performance
GuruFocus tracks the stock performance after each of James C Blair's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James C Blair is 14.65%. GuruFocus also compares James C Blair's trading performance to market benchmark return within the same time period. The performance of stocks bought by James C Blair within 3 months outperforms 6 times out of 21 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James C Blair's insider trading performs compared to the benchmark.
Performance of James C Blair
James C Blair Ownership Network
Ownership Network List of James C Blair
Ownership Network Relation of James C Blair
James C Blair Owned Company Details
What does Clovis Oncology Inc do?
Who are the key executives at Clovis Oncology Inc?
James C Blair is the director of Clovis Oncology Inc. Other key executives at Clovis Oncology Inc include See Remarks Thomas C. Harding , See Remarks Gillian C Ivers-read , and See remarks Lindsey Rolfe .
Clovis Oncology Inc (CLVSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Clovis Oncology Inc (CLVSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Clovis Oncology Inc (CLVSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Clovis Oncology Inc (CLVSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clovis Oncology Inc Insider Transactions
James C Blair Mailing Address
Above is the net worth, insider trading, and ownership report for James C Blair. You might contact James C Blair via mailing address: 5880 Pacific Center Blvd, San Diego Ca 92121-4204.